GlassScriptPhysician profile
Raman Sharma
NPI 1134562358
$45,646.95
in general payments reported to CMS, 2019-2025
32 companies · $8,319 in 2025
The $8,319 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $2,085 · 2021: $6,217 · 2022: $4,827 · 2023: $8,103 · 2024: $16K · 2025: $8,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $8,160 · Consulting Fee: $8,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,208.32 |
| Food and Beverage | $8,160.49 |
| Consulting Fee | $8,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,864.27 | 2021-2025 | Symplicity G3, Hawkone, Abre |
| Cagent Vascular INC | $10,670.70 | 2022-2025 | Serrantor |
| Abbott Laboratories | $8,402.96 | 2020-2025 | Supera, Jeti, Perclose Prostyle |
| Shockwave Medical, INC | $1,771.43 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $999.04 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $652.82 | 2021-2023 | Lutonix Drug Coated Balloon, Crosser Iq |
| Boston Scientific Corporation | $502.89 | 2021-2025 | Varithena Administration Pack, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $473.91 | 2020-2021 | |
| Amgen INC. | $368.34 | 2021-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $325.85 | 2022-2025 | |
| Terumo Medical Corporation | $308.67 | 2020-2025 | Glidewire, Angio-Seal |
| Becton, Dickinson and Company | $232.20 | 2024 | Venovo |
| Pfizer INC. | $227.98 | 2020-2023 | |
| Abiomed | $207.38 | 2020 | |
| Recor Medical INC | $195.76 | 2024 | Paradise Renal Denervation System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $179.40 | 2023 | Torus Stent Graft System |
| Genentech USA, INC. | $149.84 | 2019 | |
| Philips North America LLC | $146.77 | 2021 | |
| Janssen Pharmaceuticals, INC | $132.90 | 2021-2022 | |
| Chiesi USA, INC. | $132.87 | 2021-2022 | |
| Incyte Corporation | $124.75 | 2021 | |
| W. L. Gore & Associates, INC. | $116.46 | 2021-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Pharmacosmos Therapeutics INC. | $100.52 | 2025 | Monoferric |
| Tactile Systems Technology INC | $93.90 | 2022-2025 | Nimbl, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $82.72 | 2020-2022 | |
| Cardiva Medical, INC. | $41.10 | 2021 | |
| Reflow Medical INC | $38.69 | 2023 | |
| Abbvie INC. | $27.44 | 2022 | |
| Biotronik INC. | $23.86 | 2022 | |
| Cordis US Corp. | $20.59 | 2023 | Zephyr |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.57 | 2024 | Lifevest |
| Teleflex LLC | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raman Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.